Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Introduction. Ziprasidone appears to offer important therapeutic and tolerability advantages over conventional, and some novel, antipsychotics.

× No keyword cloud information.

14 in total

1. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.

Authors: C Prakash; A Kamel; J Gummerus; K Wilner
Journal: Drug Metab Dispos Date: 1997-07 Impact factor: 3.922

2. Antipsychotic drugs, neurotransmitters, and schizophrenia.

Authors: A Carlsson
Journal: Am J Psychiatry Date: 1978-02 Impact factor: 18.112

Review 3. The future of neuroleptic psychopharmacology.

Authors: A Ortiz; S Gershon
Journal: J Clin Psychiatry Date: 1986-05 Impact factor: 4.384

Review 4. Side effect profiles of new antipsychotic agents.

Authors: D E Casey
Journal: J Clin Psychiatry Date: 1996 Impact factor: 4.384

5. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

Authors: L Farde; H Hall; E Ehrin; G Sedvall
Journal: Science Date: 1986-01-17 Impact factor: 47.728

6. Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group.

Authors: J Peuskens
Journal: Br J Psychiatry Date: 1995-06 Impact factor: 9.319

Review 7. New atypical antipsychotic medications.

Authors: M D Jibson; R Tandon
Journal: J Psychiatr Res Date: 1998 May-Aug Impact factor: 4.791

8. Risperidone in the treatment of schizophrenia.

Authors: S R Marder; R C Meibach
Journal: Am J Psychiatry Date: 1994-06 Impact factor: 18.112

9. Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors.

Authors: J E Leysen; P M Janssen; A Schotte; W H Luyten; A A Megens
Journal: Psychopharmacology (Berl) Date: 1993 Impact factor: 4.530

10. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.

Authors: T F Seeger; P A Seymour; A W Schmidt; S H Zorn; D W Schulz; L A Lebel; S McLean; V Guanowsky; H R Howard; J A Lowe
Journal: J Pharmacol Exp Ther Date: 1995-10 Impact factor: 4.030

1 in total

Review 1. Pharmacokinetics and therapeutics of acute intramuscular ziprasidone.

Authors: Sheldon H Preskorn
Journal: Clin Pharmacokinet Date: 2005 Impact factor: 5.577

1 in total